Patents by Inventor Martine Piccart

Martine Piccart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170273934
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor negative” breast cancer.
    Type: Application
    Filed: June 12, 2017
    Publication date: September 28, 2017
    Applicant: SynCore Biotechnology Co., Ltd
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • Patent number: 9707204
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor negative” breast cancer.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: July 18, 2017
    Assignee: SYNCORE BIOTECHNOLOGY CO., LTD.
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • Publication number: 20150359778
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor negative” breast cancer.
    Type: Application
    Filed: August 24, 2015
    Publication date: December 17, 2015
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • Patent number: 9144563
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor negative” breast cancer.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: September 29, 2015
    Assignee: Medigene AG
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • Publication number: 20120183604
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of “triple receptor negative” breast cancer.
    Type: Application
    Filed: March 26, 2012
    Publication date: July 19, 2012
    Inventors: Kay-Oliver KLICHE, Axel MESCHEDER, Martine Piccart
  • Patent number: 8168216
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of ‘triple receptor negative’ breast cancer.
    Type: Grant
    Filed: March 16, 2007
    Date of Patent: May 1, 2012
    Assignee: MediGene AG
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • Publication number: 20120071346
    Abstract: The present invention is related to the methods and systems for prognosis determination in tumor samples, by measuring gene expression in a tumor sample and applying a gene-expression grade index (GGI) or a relapse score (RS) to yield a number c risk score.
    Type: Application
    Filed: November 29, 2011
    Publication date: March 22, 2012
    Applicant: Universite Libre de Bruxelles
    Inventors: Christos SOTIRIOU, Mauro Delorenzi, Martine Piccart, Virginie Durbecq
  • Publication number: 20090186078
    Abstract: The present invention relates to the use of a liposomal preparation for the manufacture of a pharmaceutical composition and the use of such a composition for the treatment of ‘triple receptor negative’ breast cancer.
    Type: Application
    Filed: March 16, 2007
    Publication date: July 23, 2009
    Inventors: Kay-Oliver Kliche, Axel Mescheder, Martine Piccart
  • Publication number: 20080275652
    Abstract: Gene-Based Algorithmic Cancer Prognosis relates to methods and systems for prognosis determination in tumor samples. The methods and systems measure gene expression in a tumor sample and applying a gene-expression grade index (GGI) or a relapse score (RS) to yield a number c risk score.
    Type: Application
    Filed: October 30, 2007
    Publication date: November 6, 2008
    Applicant: Universite Libre de Bruxelles
    Inventors: Christos SOTIRIOU, Mauro DELORENZI, Martine PICCART, Virginie DURBECQ